FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19729511000001101: Ciprofloxacin 250mg tablets (Medreich Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Dec 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66731401000001118 Ciprofloxacin 250mg tablets (Medreich Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66731501000001119 Ciprofloxacin 250mg tablets (Medreich Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciprofloxacin 250mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Is a Ciprofloxacin 250mg tablets true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Is a Ciprofloxacin 250mg tablets false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Is a Product containing precisely ciprofloxacin 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has active ingredient Ciprofloxacin false Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has specific active ingredient Ciprofloxacin hydrochloride true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) Has basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ciprofloxacin 250mg tablets (Medreich Plc) 10 tablet Has AMP True Ciprofloxacin 250mg tablets (Medreich Plc) Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Medreich Plc) 20 tablet Has AMP True Ciprofloxacin 250mg tablets (Medreich Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start